p53-Independent Activities of MDM2 and Their Relevance to Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|5|1|9-20

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.5, Iss.1, 2005-02, pp. : 9-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting MDM2-p53 Interaction for Cancer Therapy: Are We There Yet?

By  

Current Medicinal Chemistry, Vol. 21, Iss. 5, 2014-02 ,pp. : 553-574

Bentham Science Publishers

Access to resources Recommend Favorite

Reactivation of p53 by Novel MDM2 Inhibitors: Implications for Pancreatic Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 10, Iss. 3, 2010-05 ,pp. : 319-331

Bentham Science Publishers

Access to resources Recommend Favorite

P53 Mdm2 Inhibitors

By  

Current Pharmaceutical Design, Vol. 18, Iss. 30, 2012-10 ,pp. : 4668-4678

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Modeling Approaches in the Discovery of New Drugs for Anti-Cancer Therapy: The Investigation of p53-MDM2 Interaction and its Inhibition by Small Molecules

By  

Current Medicinal Chemistry, Vol. 17, Iss. 28, 2010-09 ,pp. : 3142-3154

Bentham Science Publishers

Access to resources Recommend Favorite

Implications of endoplasmic reticulum stress, the unfolded protein response and apoptosis for molecular cancer therapy. Part I: targeting p53, Mdm2, GADD153/CHOP, GRP78/BiP and heat shock proteins

By Hiss Donavon C   Gabriels Gary A  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 8, 2009-08 ,pp. : 799-821

Informa Healthcare

Access to resources Recommend Favorite